有希望的男人People with HIV at higher risk of COVID reinfection: CDC_我的网站
一 | People with HIV are at increased risk of being reinfected with the virus that causes COVID-19, according to new federal data.Researchers from the Centers for Disease Control and Prevention and the Chicago Department of Public Health followed adult residents in Chicago from their first reported infection from March 2020 through the end of May 2022, according to the report published Wednesday by the CDC.The team compared COVID test laboratory data and COVID vaccine administration data to Chicago's Enhanced HIV/AIDS Reporting System.About 5% experienced reinfection among more than 453,000 Chicago residents who tested positive for the virus.Rates of reinfection were higher among people with HIV (6.7%) than among people without HIV (5.2%).People with HIV are more likely to have completed a primary COVID vaccine series plus a booster before their reinfection -- 31.8% versus 27% for those without HIV.Reinfection rates were consistently higher throughout the pandemic for people with HIV and were highest during the original omicron variant phase, according to the report."Understanding if persons with HIV have a higher risk for SARS-CoV-2 reinfection may help tailor future COVID-19 public health guidance," the authors wrote. "[Persons with HIV] should follow the recommended COVID-19 vaccine schedule, including booster doses, to avoid SARS-CoV-2 reinfections."Those who were reinfected were more likely to be male, older and Black or African American compared to those without HIV, the study found.People with HIV were also less likely to have been unvaccinated at the time of their first infection compared to people without HIV.The report notes the findings are a reminder about the risks of reinfection for those who are immunocompromised.HIV can weaken the immune system, infecting and destroying CD4 cells, which causes the white blood cell count to drop and compromises the immune system.This means that people with HIV are susceptible to COVID infection especially those who are not on antiretroviral therapy (ART).ART is a combination of drugs that suppresses a person's viral load until HIV Is virtually undetectable. The ability of ART to control viral replication has been shown to greatly improve immune system function, studies show."Evaluating the association between HIV infection and SARS-CoV-2 reinfections using surveillance data can help strengthen public health recommendations including the need for extra doses as part of a primary series, booster doses of vaccine, and optimized ART in [persons with HIV]," the authors wrote. "Tailored guidance and prevention messaging for [persons with HIV] can help reduce the elevated risk we identified in this analysis and limit continued SARS-CoV-2 transmission."。 广州：集中力量支持核心技术攻关加快推动重大科技成果转化 人民财讯8月25日电，8月24日上午，广州市市长孙志洋主持召开市政府常务会议，会议研究了科技创新资金统筹管理工作。会议强调，要立足全市科技创新“一盘棋”高度，完善制度机制，改进管理办法，健全管理标准，对科技资金实行归集管理，围绕科技创新强市建设目标同向发力，集中力量支持关键核心技术攻关和重大科技成果转化。要充分发挥企业创新主体作用，通过办好创新创业赛事、搭建成果展示与对接平台，有效发挥赛事招商引智、促进成果转化和项目落地的重要功能。要紧扣国家、省重大科技战略部署及全市现代化产业体系建设，精准投向科技创新与产业创新深度融合的关键领域和重点项目，切实增强科创资金的指向性、精准性和有效性。 。 Current article:http://z8v34u.suiyangguiduanzudoushaopao.buzz/news/20260826_57460.html Published on:03:11:55 |
